A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis

Overview of attention for article published in Frontiers in Neurology, September 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 11,710 followers.

IoN UCL PubMed: A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis https://t.co/RY0yiD41K2

09 Oct 2023

Reply Repost Favourite

New Research: A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis: Background Alemtuzumab (ALZ) is a pulsed immune reconstitution therapy for… #Neurology https:/

21 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.